CCOC(=O)C1=CC[C@H]2c3c(c4ccccc4n3C)C(=O)C1N2C(=O)OC(C)(C)C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?